This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
BrainsWay Deep TMS technology, along with Achieve TMS in California, was featured as a novel treatment option for depressed patients on CBS This Morning’s special broadcast: Stop the Stigma: A Conversation About Mental Health. A patient describes her experience being lifted out of depression with this unique treatment option, after medication and therapy did not work for her.